Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
---|---|
Information provided by: | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
ClinicalTrials.gov Identifier: | NCT00083486 |
The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.
Condition | Intervention | Phase |
---|---|---|
Anemia |
Drug: epoetin alfa |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
United States, Arkansas | |
Heritage Physician Group-Oncology | |
Hot Springs, Arkansas, United States, 71913 | |
United States, Georgia | |
Spalding Oncology Services | |
Griffin, Georgia, United States, 30224 | |
United States, Illinois | |
Southern Illinois Hematology | |
Centralia, Illinois, United States, 62801 | |
United States, Maryland | |
BioLab Research | |
Rockville, Maryland, United States, 20852 | |
United States, New York | |
Slocum-Dickson Medical Group, PC | |
New Hartford, New York, United States, 13413 | |
United States, North Carolina | |
NorthEast Urology Research | |
Concord, North Carolina, United States | |
United States, Ohio | |
Mid Ohio Oncology Hematology | |
Columbus, Ohio, United States, 43213 | |
United States, Pennsylvania | |
Drexel University College of Medicine | |
Philadelphia, Pennsylvania, United States, 19102 | |
United States, South Carolina | |
Charleston Cancer Care | |
Charleston, South Carolina, United States, 29406 | |
Charleston Hematology Oncology | |
Charleston, South Carolina, United States, 29403 | |
Caroline Cancer Center | |
Aiken, South Carolina, United States, 29403 | |
United States, Tennessee | |
Volunteer Research Group | |
Knoxville, Tennessee, United States, 37920 |
Study ID Numbers: | EPO-CAN-203 |
Study First Received: | May 24, 2004 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00083486 |
Health Authority: | United States: Food and Drug Administration |
Epoetin Alfa Hematologic Diseases Anemia |
Hematinics Therapeutic Uses Hematologic Agents Pharmacologic Actions |